1. Sadda SriniVas R
2. Keane Pearse A

9789350255797

10.5005/jp/books/11557_28

1/e

2012

18

1. Doheny Eye Institute Keck School of Medicine, University of Southern California, Los Angeles, USA, Doheny Eye Institute, University of Southern California, Los Angeles, USA, Doheny Image Reading Center, Doheny Eye Institute, Keck School of Medicine, University of Southern California, USA, University of California-Los Angeles, Los Angeles, California, USA
2. Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, USA, Moorfields Eye Hospital, London, United Kingdom, University College London, Institute of Ophthalmology, London, UK

Neovascular age-related macular degeneration, choroidal neovascularization, retinal pigment epithelium, verteporfin, photodynamic therapy, VEGF inhibition, vascular endothelial growth factor, pegaptanib, ranibizumab, anti-VEGF drug, VEGF-A, VEGF165, platelet-derived growth factor, VEGF-B, VEGF-C, VEGF-D, VEGF-E, Bruch’s membrane, VEGF121, optical coherence tomography, arterial thromboembolic events, CNV leakage, bevacizumab, extrafoveal location, angiographic lesion, fluorescein angiography, anti-VEGF therapy, verteporfin PDT, anti-VEGF tachyphylaxis, polypoidal choroidal vasculopathy, VEGF trap